Global access to antiretroviral treatment in many places remains unacceptably low. With the latest guidelines recommending treatment for all people living with HIV, programmes and funding need to be scaled up.
Programmes need to follow the treatment cascade to ensure effective linking from testing to treatment and finally, viral suppression.
It is vital that programmes are specific to key populations and take co-infections into account.
With every person living with HIV now recommended to start treatment, funding needs to be scaled up.
Follow the steps on the HIV treatment cascade from testing to treatment, and finally viral suppression.
HIV drug resistance has the potential to become a serious emerging threat to the roll-out of treatment programmes globally.
